Alternative splicing in the lung influences COVID-19 severity and respiratory diseases
View ORCID ProfileTomoko Nakanishi, Yossi Farjoun, Julian Willett, Richard J. Allen, Beatriz Guillen-Guio, Sirui Zhou, J. Brent Richards
doi: https://doi.org/10.1101/2022.10.18.22281202
Tomoko Nakanishi
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
3Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4Research Fellow, Japan Society for the Promotion of Science, Tokyo, Japan
Yossi Farjoun
2Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
Julian Willett
2Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
5Quantitative Life Sciences Program, McGill University, Montréal, Canada
6McGill Genome Centre, McGill University, Montréal, Québec, Canada
Richard J. Allen
7Department of Health Sciences, University of Leicester, Leicester, United Kingdom
Beatriz Guillen-Guio
7Department of Health Sciences, University of Leicester, Leicester, United Kingdom
Sirui Zhou
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
5Quantitative Life Sciences Program, McGill University, Montréal, Canada
6McGill Genome Centre, McGill University, Montréal, Québec, Canada
J. Brent Richards
1Department of Human Genetics, McGill University, Montréal, Québec, Canada
2Centre for Clinical Epidemiology, Department of Medicine, Lady Davis Institute, Jewish General Hospital, McGill University, Montréal, Québec, Canada
8Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
9Department of Twin Research, King’s College London, London, United Kingdom
105 Prime Sciences Inc, Montréal, Québec, Canada
Posted October 20, 2022.
Alternative splicing in the lung influences COVID-19 severity and respiratory diseases
Tomoko Nakanishi, Yossi Farjoun, Julian Willett, Richard J. Allen, Beatriz Guillen-Guio, Sirui Zhou, J. Brent Richards
medRxiv 2022.10.18.22281202; doi: https://doi.org/10.1101/2022.10.18.22281202
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (715)
- Anesthesia (210)
- Cardiovascular Medicine (2989)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12873)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4669)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2969)
- Health Policy (1079)
- Hematology (394)
- HIV/AIDS (941)
- Medical Education (433)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4450)
- Nursing (239)
- Nutrition (654)
- Oncology (2316)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (329)
- Pain Medicine (287)
- Palliative Medicine (85)
- Pathology (505)
- Pediatrics (1207)
- Primary Care Research (506)
- Public and Global Health (7047)
- Radiology and Imaging (1563)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (60)
- Transplantation (214)
- Urology (186)